|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.840
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.523
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.518
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.431
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.424
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.300
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.273
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.270
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.265
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.252
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.231
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.225
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.216
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.216
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.197
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.190
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.177
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.172
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.171
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.161
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.159
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.151
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.148
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.147
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.146
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.145
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.140
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.138
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.137
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.137
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.135
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.131
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.130
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.122
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.121
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.116
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.116
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.114
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.109
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.107
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.106
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.106
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.105
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.104
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.101
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.101
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.100
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.100
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.100
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.100
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.098
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.098
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.097
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.097
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.093
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.091
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.091
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.090
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.088
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.088
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.087
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.087
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.085
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.083
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.083
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.083
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.083
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.082
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.082
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.081
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.081
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.081
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.080
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.080
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.078
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.077
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.077
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.077
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.077
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.076
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.076
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.075
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.074
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
14 |
0.073
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.073
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.071
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.071
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.070
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.069
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.069
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.069
|
|
|
|
nk t cell proliferation
|
GO:0001866 |
2 |
0.068
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.068
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.067
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.065
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.065
|
|
|
|
melanosome transport
|
GO:0032402 |
11 |
0.064
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.064
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.063
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.063
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.062
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.062
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.061
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.061
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.060
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.060
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.060
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.060
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.060
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.060
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.059
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.059
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.058
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.058
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.057
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.057
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.057
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.057
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.055
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.055
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.055
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.054
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.054
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.054
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.053
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.053
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.053
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.053
|
|
|
|
regulation of brown fat cell proliferation
|
GO:0070347 |
1 |
0.051
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.051
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.050
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.050
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.049
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.049
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.049
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.049
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.049
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.048
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.048
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.048
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.048
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.048
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.048
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.047
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.047
|
|
|
|
translation
|
GO:0006412 |
93 |
0.046
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.046
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.046
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.045
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.045
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.044
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.044
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.044
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.043
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.043
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.043
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.042
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.042
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.042
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.042
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.041
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.039
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.039
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.039
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.039
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.039
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.038
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.038
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.038
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.038
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.038
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.038
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.037
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.036
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.036
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.036
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.036
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.035
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.035
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.035
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.034
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.034
|
|
|
|
immunoglobulin transcytosis in epithelial cells
|
GO:0002414 |
2 |
0.034
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.034
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.034
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.033
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.033
|
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.033
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.033
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.033
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.033
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.033
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.033
|
|
|
|
cellular pigmentation
|
GO:0033059 |
20 |
0.033
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.032
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.032
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.032
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.032
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.032
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.032
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.031
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.031
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.031
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.031
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
fasciculation of motor neuron axon
|
GO:0097156 |
2 |
0.031
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.031
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.031
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.031
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.030
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.030
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.030
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.030
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.030
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.030
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.030
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.029
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.029
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.029
|
|
|
|
adherens junction maintenance
|
GO:0034334 |
1 |
0.029
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.029
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.029
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.029
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.029
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.029
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.029
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.029
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.029
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.029
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.028
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.028
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.028
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.028
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.028
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.028
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.028
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.028
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.028
|
|
|
|
prostate glandular acinus development
|
GO:0060525 |
12 |
0.027
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.027
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.027
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.027
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.027
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.027
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.027
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.027
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.027
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.027
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.027
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.027
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.027
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.026
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.026
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.026
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.026
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.026
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.026
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.026
|
|
|
|
notochord cell development
|
GO:0060035 |
1 |
0.025
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.025
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.025
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.025
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.025
|
|
|
|
establishment of pigment granule localization
|
GO:0051905 |
12 |
0.025
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.025
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.025
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.025
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.025
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.025
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.024
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.024
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.024
|
|
|
|
negative regulation of macrophage activation
|
GO:0043031 |
2 |
0.024
|
|
|
|
t helper 2 cell activation
|
GO:0035712 |
2 |
0.024
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.024
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.024
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.024
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.024
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.024
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.023
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.023
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.023
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.023
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.023
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.023
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.023
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.023
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.023
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.023
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.023
|
|
|
|
negative regulation of epithelial to mesenchymal transition
|
GO:0010719 |
6 |
0.023
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.023
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.023
|
|
|
|
entry into host
|
GO:0044409 |
15 |
0.023
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.022
|
|
|
|
negative regulation of meiotic cell cycle phase transition
|
GO:1901994 |
3 |
0.022
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.022
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.022
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.022
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.022
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.022
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.022
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.022
|
|
|
|
pigment granule localization
|
GO:0051875 |
13 |
0.022
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.022
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.022
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.022
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.022
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.021
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.021
|
|
|
|
brown fat cell proliferation
|
GO:0070342 |
1 |
0.021
|
|
|
|
insulin secretion involved in cellular response to glucose stimulus
|
GO:0035773 |
36 |
0.021
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.021
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.021
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.021
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.021
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.021
|
|
|
|
organ or tissue specific immune response
|
GO:0002251 |
13 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.021
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.021
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.020
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase activity
|
GO:0043552 |
11 |
0.020
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.020
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.020
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.020
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.020
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.020
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.020
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.020
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.020
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.020
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.020
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.020
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.020
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.020
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.019
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
|
response to water
|
GO:0009415 |
1 |
0.019
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.019
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.019
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.019
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.019
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.018
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.018
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.018
|
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.018
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.018
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
16 |
0.018
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.018
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.018
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.018
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.017
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.017
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.017
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.017
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.017
|
|
|
|
regulation of lateral mesodermal cell fate specification
|
GO:0048378 |
2 |
0.017
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.017
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.017
|
|
|
|
establishment of melanosome localization
|
GO:0032401 |
11 |
0.017
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.017
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.017
|
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.017
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.017
|
|
|
|
metanephric capsule development
|
GO:0072213 |
1 |
0.017
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.017
|
|
|
|
positive regulation of long term neuronal synaptic plasticity
|
GO:0048170 |
3 |
0.017
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.017
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.017
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.017
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.016
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.016
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.016
|
|
|
|
detection of glucose
|
GO:0051594 |
1 |
0.016
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.016
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.016
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.016
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.016
|
|
|
|
dichotomous subdivision of terminal units involved in ureteric bud branching
|
GO:0060678 |
1 |
0.016
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.016
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.016
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.016
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.016
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.016
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.016
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.016
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.016
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.016
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
epithelial cell differentiation involved in mammary gland alveolus development
|
GO:0061030 |
4 |
0.016
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.016
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.015
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.015
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.015
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
18 |
0.015
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.015
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.015
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.015
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.015
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.015
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.015
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.015
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.015
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.015
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.015
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.015
|
|
|
|
regulation of blood vessel endothelial cell migration
|
GO:0043535 |
12 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.015
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.015
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.015
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.015
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.015
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.014
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.014
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.014
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.014
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.014
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.014
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.014
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.014
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.014
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.014
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.014
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.014
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.014
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
positive regulation of thyroid hormone generation
|
GO:2000611 |
2 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.014
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.014
|
|
